Evidence map›Paper›PMID 36232811›Full record

ReviewInternational journal of molecular sciences2022

Nanomaterials: A Review about Halloysite Nanotubes, Properties, and Application in the Biological Field.

Giuseppa Biddeci, Gaetano Spinelli, Paolo Colomba, Francesco Di Blasi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Multifunctional Nanomaterials: Synthesis, Properties, and Applications 2.0.International journal of molecular sciences · 2023
    Article
  18. Halloysite Nanotubes and Sepiolite for Health Applications.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giuseppa BiddeciInstitute for Innovation and Biomedical Research (IRIB), 90146 Palermo, CNR, Italy.
Gaetano SpinelliInstitute for Innovation and Biomedical Research (IRIB), 90146 Palermo, CNR, Italy.
Paolo ColombaInstitute for Innovation and Biomedical Research (IRIB), 90146 Palermo, CNR, Italy.ORCID 0000-0002-2470-7030
Francesco Di BlasiInstitute for Innovation and Biomedical Research (IRIB), 90146 Palermo, CNR, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of synthetic materials and the attention towards environmental hazards and toxicity impose the development of green composites with natural origins. Clay is one of the candidates for this approach. Halloysite is a natural clay mineral, a member of the Kaolin group, with characteristic tubular morphology, usually named halloysite nanotubes (HNTs). The different surface chemistry of halloysite allows the selective modification of both the external surface and the inner lumen by supramolecular or covalent interactions. An interesting aspect of HNTs is related to the possibility of introducing different species that can be released more slowly compared to the pristine compound. Due to their unique hollow morphology and large cavity, HNTs can be employed as an optimal natural nanocarrier. This review discusses the structure, properties, and application of HNTs in the biological field, highlighting their high biocompatibility, and analyse the opportunity to use new HNT hybrids as drug carriers and delivery systems.

Indexed as

KaolinNanotubesClayDrug CarriersMineralsClayDrug CarriersKaolinMineralsbiocompatibilitybiomedical applicationdrug delivery systemhalloysite nanotubes

Identifiers

PMID36232811
PMCPMC9570192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.